3.04
-0.11(-3.49%)
Currency In USD
| Previous Close | 3.15 |
| Open | 3.14 |
| Day High | 3.22 |
| Day Low | 3.04 |
| 52-Week High | 6.26 |
| 52-Week Low | 0.64 |
| Volume | 19,608 |
| Average Volume | 94,220 |
| Market Cap | 13.83M |
| PE | -2.55 |
| EPS | -1.19 |
| Moving Average 50 Days | 3.67 |
| Moving Average 200 Days | 3.49 |
| Change | -0.11 |
If you invested $1000 in Lixte Biotechnology Holdings, Inc. (LIXT) 10 years ago, it would be worth $168.89 as of February 21, 2026 at a share price of $3.04. Whereas If you bought $1000 worth of Lixte Biotechnology Holdings, Inc. (LIXT) shares 5 years ago, it would be worth $82.16 as of February 21, 2026 at a share price of $3.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
GlobeNewswire Inc.
Feb 18, 2026 1:00 PM GMT
BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has ap
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE
GlobeNewswire Inc.
Jan 21, 2026 1:00 PM GMT
Event Sponsored by LIXTE Biotechnology Holdings,Developer of Breakthrough Cancer Therapies Atlanta, GA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Inspired by the music, legacy, and lived experiences of De La Soul, the inaugural Good Health: Mind, Body & So
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
GlobeNewswire Inc.
Jan 20, 2026 1:00 PM GMT
BOCA RATON, Fla., Jan. 20, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical-stage pharmaceutical company advancing LB-100, a first-in-class inhibitor of protein phosphatase 2A (PP2A),